Search

Search Constraints

You searched for: Author/Creator Post, F

Search Results

1. Healthcare delivery for HIV‐positive people with tuberculosis in Europe. Issue 4 (20th November 2020)

2. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018)